The mTOR-Dop1a-Agpat2 axis regulates nuclear phospholipid homeostasis

Hirotaka Ariyama1, Atsushi Tsukamura2, Satoko Miyatake3,4,5

  • 1Department of Pediatric Physiology, Innovation & Research Support Center, Graduate School, International University of Health and Welfare, Tokyo, Japan.

Iscience
|May 21, 2026
PubMed

Insights

Dop1a protein regulates nuclear phospholipid synthesis, preventing lipid droplet formation and ensuring proper cell division. Its dysfunction is linked to neurodevelopmental disorders.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Neuroscience

Background:

  • Nuclear phospholipid metabolism is poorly understood.
  • Dop1a's role in nuclear lipid homeostasis is unknown.
  • mTOR signaling influences nuclear lipid metabolism.

Purpose of the Study:

  • To elucidate the function of Dop1a in regulating nuclear phospholipid metabolism.
  • To investigate the link between Dop1a, mTOR signaling, and nuclear lipid synthesis.
  • To determine the role of Dop1a in cell cycle regulation and neurodevelopment.

Main Methods:

  • Investigated Dop1a localization and binding partners (AGPAT2) at nuclear pore complexes.
  • Analyzed phospholipid levels and nuclear lipid droplet formation in wild-type and Dop1a-deficient cells.
  • Assessed the impact of Dop1a on cell cycle progression and CDK2 nuclear accumulation.
  • Examined Dop1a expression in neurons and the consequences of its mutations in neurodevelopmental disorders.

Main Results:

  • Dop1a localizes to nuclear pore complexes upon lysophosphatidic acid shortage, suppressing phospholipid synthesis by inhibiting AGPAT2.
  • Loss of Dop1a leads to increased phospholipid production and nuclear lipid droplet formation.
  • Dop1a restricts CDK2 nuclear accumulation, coordinating phospholipid levels with cell cycle entry.
  • Dop1a is crucial for neurobehavioral development, and its mutations are associated with neurodevelopmental disorders.

Conclusions:

  • Dop1a acts as a key regulator of nuclear phospholipid homeostasis, safeguarding cell division.
  • Dop1a's function is essential for proper nervous system development.
  • Dysregulation of Dop1a is implicated in neurodevelopmental disorders, highlighting its clinical relevance.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...